OCT 26·SEC EDGARLow
Glover Nicholas purchased $13K of LITS
Glover Nicholas purchased 2,000 shares of Lite Strategy, Inc. (LITS) at an average of $6.28 ($6.00–$6.55) across 2 trades over 2025-07-22 to 2025-07-23.
StockNASDAQ · US · USDHealthcare · BIOTECHNOLOGY
$LITS
Lite Strategy, Inc.
Price · $LITSvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $LITS in the last 7 days.
Insider · 30dAll trades →
No SEC Form 4 filings for $LITS in the last 30 days.
See all $LITS insider activity →Top stories · $LITSMore →
SEP 29·news.alphastreet.com
Lite Strategy (LITS): Litecoin Treasury Strategy Enters the Execution Test
Lite Strategy, Inc. (LITS), formerly MEI Pharma, now focuses on Litecoin as a treasury reserve asset. By fiscal 2026, it accumulated 832,716 Litecoin tokens and operates debt-free. The company's strategy includes active treasury management, share repurchases, and investments in the Litecoin ecosystem. Management aims to increase Litecoin backing per share, but investors face volatility and valuation questions due to mark-to-market accounting and regulatory risks.
SEP 28·scanx.trade
Lite Strategy Q4 Results: Loss per share narrows 5% YoY to $0.38
Lite Strategy (NASDAQ: LITS) reported a Q4 loss of $0.38 per share, a 5% improvement from $0.40 per share in the prior year. The company did not disclose other financial metrics. The loss reduction indicates slight progress in financial performance.
LITS sentiment & insider activity
Recent LITS coverage spans earnings, financial news and insider activity.
What's driving LITS
Small insider purchase may signal modest confidence but unlikely to move price.
Earnings are highly sensitive to Litecoin price movements and the company's treasury strategy.
Loss improvement may ease short‑term pressure.
The larger-than-expected loss and zero revenue suggest deteriorating fundamentals and heightened exposure to cryptocurrency volatility.
The buyback and higher Litecoin per share can support per-share value optics, but the filing provides limited detail on valuation or near-term earnings impact.
AlphAI scores every news story that mentions LITS with an AI model for sentiment and relevance, and aggregates insider trades from Lite Strategy, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $LITS
Score
Glover Nicholas purchased $13K of LITS
Glover Nicholas purchased 2,000 shares of Lite Strategy, Inc. (LITS) at an average of $6.28 ($6.00–$6.55) across 2 trades over 2025-07-22 to 2025-07-23.
1 min read
Lite Strategy (LITS): Litecoin Treasury Strategy Enters the Execution Test
Lite Strategy, Inc. (LITS), formerly MEI Pharma, now focuses on Litecoin as a treasury reserve asset. By fiscal 2026, it accumulated 832,716 Litecoin tokens and operates debt-free. The company's strategy includes active treasury management, share repurchases, and investments in the Litecoin ecosystem. Management aims to increase Litecoin backing per share, but investors face volatility and valuation questions due to mark-to-market accounting and regulatory risks.
2 min readLite Strategy Q4 Results: Loss per share narrows 5% YoY to $0.38
Lite Strategy (NASDAQ: LITS) reported a Q4 loss of $0.38 per share, a 5% improvement from $0.40 per share in the prior year. The company did not disclose other financial metrics. The loss reduction indicates slight progress in financial performance.
1 min read
Lite Strategy, Inc. FY 2026: Net loss $(71.2M), EPS $(2.06) — 10-K Summary
Lite Strategy, Inc. reported a net loss of $71.2M for FY 2026, worsening from a $15.9M loss in FY 2025, with no revenue in either year. The company pivoted to Litecoin (LTC) as its primary reserve strategy, discontinuing oncology programs and focusing on non-oncologic R&D. Management initiated share repurchases and a covered call options program to manage capital and LTC exposure.
1 min readLite Strategy, Inc. (LITS): Results of Operations and Financial Condition
Lite Strategy, Inc. (LITS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share Lite Strategy Buys Back Roughly 4.9 Million Shares at an Average Price of $1.11 with No Debt Incurred SAN DIEGO, July 30, 2026 — Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Str
4 min readFlynn James P purchased $21K of LITS
Flynn James P purchased 25,000 shares of Lite Strategy, Inc. (LITS) at $0.86 on 2026-06-24.
2 min read
James Flynn Purchases 70,000 Shares of Lite Strategy (NASDAQ:LITS) Stock
Director James Flynn recently acquired 70,000 shares of Lite Strategy (NASDAQ:LITS) for $98,000, significantly increasing his direct ownership. This purchase occurred shortly after the company authorized a $25 million share buyback program, suggesting management views the stock as undervalued. Lite Strategy shares are currently trading around $1.41, with a market capitalization of $51.86 million, and analysts generally rate the stock as a "Sell".
4 min readLite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations
Lite Strategy Reports Q1 FY'26 Results. Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations ...
3 min readLite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026
Lite Strategy, Inc. marks the 14th anniversary of Litecoin and provides investors immediate access to LTC's institutional potential ...
3 min read